UVLF University portalUniversity of Veterinary Medicine and Pharmacy in Košice
Slovenčina English

Main menu

PublicationsHuman truncated tau is using a different mechanism from amyloid-ß to damage the blood-brain barrier

Human truncated tau is using a different mechanism from amyloid-ß to damage the blood-brain barrier

Back

Bibliographic information

Publication year
2009
Category
ADC — Scientific papers in foreign journals
CREPČ / EPCA ID
0015359
Document type
Journal article
Source
Journal Of Alzheimers Disease
ISSN (Source)
1387-2877
Volume
Vol. 18, č. 4(2009), s. 897-906
Language
English

Bibliographic record

KOVÁČ, Andrej - ŽILKOVÁ, Miroslava - DELI, Mária Anna - ŽILKA, Norbert - NOVÁK, Michal. Human truncated tau is using a different mechanism from amyloid-ß to damage the blood-brain barrier. In: Journal Of Alzheimers Disease. 2009. ISSN 1387-2877, Vol. 18, č. 4(2009), s. 897-906. (2009: 3.832 - IF, 127 - H-index, 4.814 - IF 5y, 1.577 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 1.299 - ABDC).

Publication authors

AuthorRoleShare
Andrej KováčAuthor0.000 %
Miroslava ŽilkováAuthor0.000 %
Mária Anna DeliAuthor0.000 %
Norbert ŽilkaAuthor0.000 %
Michal NovákAuthor0.000 %

Metrics

IF 3.832IF5 4.814SJR Q 1JCR Q 2SJR 1.577H-index 127ABDC 1.299Metrics year 2009

Citations (4)

Citation year / CategoryCitationsSource
2012
1

BANKS, William A. Drug delivery to the brain in Alzheimer's disease: Consideration of the blood-brain barrier. In ADVANCED DRUG DELIVERY REVIEWS, 2012, vol.64, no.7, 629.

 WoS
2012
1

BROUSSARD, G.J. - MYTAR, J. - LI, R.-C. - KLAPSTEIN, G.J. The role of inflammatory processes in Alzheimer's disease. In Inflammopharmacology, 2012, vol.20, no.3, 109-126.

 Scopus
2011
1

HUMPEL, C. Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease? In Experimental Gerontology, 2011, vol.46, no.4, 225-232.

 Scopus
2011
1

JAWORSKI, T. - LECHAT, B. - DEMEDTS, D. - GIELIS, L. - DEVIJVER, H. - BORGHGRAEF, P. - DUIMEL, H. - VERHEYEN, F. - KGLER, S. - VAN LEUVEN, F. Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration. In American Journal of Pathology, 2011, vol.179, no.4, 2001-2015.

 Scopus